Author Archive: Jeremy Parkinson
It’s Time For A “Tactical Rally” In Bond Markets: Deutsche Bank
If last week marked the “throwing in the towel” moment for Deutsche Bank’s Dominic Konstam with regard to the prospect of higher long-end rates, this week looks to mark a complete rethink of his team’s thesis (at least in the near-term). Yes, Konstam’s latest note (out a day early this week to account for the holiday) still […]
Emerging Markets: What Has Changed This Week
Malaysia’s central bank said it will allow investors to fully hedge their currency exposure. Egypt declared a 3-month state of emergency after two deadly church attacks. South Africa’s parliamentary no confidence vote has been delayed Argentina central bank surprised markets with a 150 bp hike to 26.25%. Brazil central bank accelerated the easing cycle with […]
EC Stock Exchange: Three Contrarian Ideas
Every trader wants to be a contrarian. You get to be the “smart money.” You buy low and sell high. Buy the dips and sell the rips. Contrarians may not always be right, but they certainly get attention. Brett Steenbarger, everyone’s favorite expert on trading, did a study of this in 2006. He compared two […]
Yen Stalls Despite Geopolitical Concerns
Though currently recouping earlier losses, the US Dollar is still poised to end the week on a down note. Meanwhile, the Japanese Yen continues to be pushed higher on escalating geopolitical concerns. Earlier, the US President cautioned that North Korea “will be taken care of” suggesting that more nuclear tests by Pyongyang could be met […]
FDA Rejects Eli Lilly’s Blockbuster Contender Baricitinib
The FDA has rejected Eli Lilly’s (NYSE:LLY) blockbuster contender baricitinib, saying that the pharma giant will need to gather more data to determine the proper doses that should be used by patients before regulators can reconsider their decision. Written by John Carroll (ENDpts.com) The kickback marks a stunning setback for…CEO Dave Ricks, who owes investors […]
Pharma Stock Roundup: Merck Gets CRL For Label Expansion Effort, Roche Cancer Drug Tops
It was a relatively slow week with key highlights including a complete response letter (CRL) for Merck’s (MRK – Free Report) label expansion efforts for its diabetes drugs and positive data on Roche’s (RHHBY – Free Report) lung cancer treatment. Recap of the Week’s Most Important Stories Roche Cancer Drug Tops Pfizer Drug in Study: Roche’s cancer drug, Alecensa, once […]
Good Quality ETFs And Stocks For An Edgy Market
Wall Street will be on holiday for Good Friday, but investors will be on the lookout for a bunch of good and timely bets as soon as the market reopens. This is even truer given the buoyancy in the market since the beginning of the year has rested a bit lately. Geopolitical tensions are back […]
KBW Bank Index Extended Correction
The KBW Bank Index is an economic index consisting of the stocks of 24 banking companies delivering a direct exposure to the banking sector and offering a targeted view to a unique corner of the U.S. financials sector. The top banks of the index are among the biggest financial institutions in the world and three of […]
Brexit Briefing: Now It’s All About A Hard Brexit Or A Soft One
Talking Points: As we wait for the Brexit negotiations to begin, it’s crucial to decide whether the two sides will reach an agreement or the UK will leave the EU without a deal. That could mean the difference between GBP/USD at 1.10 or with the pair at 1.50. Not long ago, the Reuters news agency asked FX […]
Retail Sales Decline For Second Straight Month As Real Earnings Stagnate
For the second month in a row, retail sales declined in March as ‘hard’ data fails to live up to ‘soft’ data’s hype. This is the biggest 2-month tumble in retail sales in over two years. The full breakdown shows the biggest declines in building materials and motor vehicles. This drop in sales should not be […]
